Indo Rama Q2 FY27 PAT surges 202% YoY to ₹74 crore on 10% revenue growth
Indo Rama Synthetics reported Q2 FY27 results with total income at ₹1,344 crore, up 10% YoY. EBITDA grew 46.4% YoY to ₹117.7 crore, and PAT surged 201.8% YoY to ₹74.1 crore. For H1 FY27, PAT increased 78.3% YoY to ₹137.8 crore. The company plans to invest ₹200 crore in specialty products.
The strong financial results and the planned investment in diversification are positive developments for the company, which could have a medium-term impact on its growth and market position.
The company reported significant year-on-year growth in Profit After Tax (PAT) and EBITDA, along with revenue growth, indicating a positive financial performance.
Indo Rama Synthetics (India) Ltd. announced its financial results for the second quarter and half year ended September 30, 2026. The company reported a strong performance with revenue growth and margin expansion.
For the second quarter of FY27 (Q2 FY27), Indo Rama recorded a total income of ₹1,344.0 crore, marking a 10.0% year-on-year (YoY) increase and a 43.0% quarter-on-quarter (QoQ) rise. The EBITDA for the quarter grew by 46.4% YoY to ₹117.7 crore, with the EBITDA margin expanding to 8.8% from 6.6% in the same period last year. Profit After Tax (PAT) saw a significant jump of 201.8% YoY to ₹74.1 crore, with the PAT margin improving to 5.5% from 2.0% in Q2 FY26.
For the half year ended September 30, 2026 (H1 FY27), the total income stood at ₹2,284.2 crore, a degrowth of 9.7% YoY, attributed to supply chain issues due to geopolitical events in the Middle East. However, EBITDA for H1 FY27 grew by 24.9% YoY to ₹225.7 crore, with an improved margin of 9.9%. PAT for H1 FY27 rose by 78.3% YoY to ₹137.8 crore, and the PAT margin increased to 6.0%.
Mr. Om Prakash Lohia, Chairman & Managing Director, commented that despite challenging operating conditions and increased raw material costs due to geopolitical developments, the company delivered a strong performance. Looking ahead, the company plans to invest approximately ₹200 crore over the next 12-18 months to diversify into specialty fibre and filament products, aiming to broaden its product portfolio and support sustainable growth.
What to do with a filing like this
Indo Rama Synthetics (India) Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Indo Rama Synthetics (India) Limited. Read the original for the full detail.